US Demands Up To $3.35B From Novartis In FCA Suit

By Dani Meyer · June 30, 2015, 6:26 PM EDT

The government is seeking up to $3.35 billion in a False Claims Act suit accusing Novartis Pharmaceutical Corp. of paying illegal kickbacks to pharmacies to recommend iron-reduction drug Exjade and transplant...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

United States of America, ex rel, et al v. Novartis Pharmaceuticals Corporation

Case Number

1:11-cv-08196

Court

New York Southern

Nature of Suit

Other Statutes: False Claims Act

Date Filed

November 14, 2011